ArticleAdvanced therapeutics2022

An induced pluripotent stem cell-derived NMJ platform for study of the NGLY1-Congenital Disorder of Deglycosylation.

Trevor Sasserath et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.